plenti-UBC-gate-3xHA-pGK-PUR Citations (4)
Originally described in: The myeloma drug lenalidomide promotes the cereblon-dependent destruction of Ikaros proteins.Lu G, Middleton RE, Sun H, Naniong M, Ott CJ, Mitsiades CS, Wong KK, Bradner JE, Kaelin WG Jr Science. 2014 Jan 17;343(6168):305-9. doi: 10.1126/science.1244917. Epub 2013 Nov 29. PubMed Journal
Articles Citing plenti-UBC-gate-3xHA-pGK-PUR
| Articles | 
|---|
| Icaritin promotes the osteogenesis of bone marrow mesenchymal stem cells via the regulation of sclerostin expression. Wei Q, Wang B, Hu H, Xie C, Ling L, Gao J, Cao Y. Int J Mol Med. 2020 Mar;45(3):816-824. doi: 10.3892/ijmm.2020.4470. Epub 2020 Jan 20. PubMed | 
| Spatiotemporal proteomic profiling of cellular responses to NLRP3 agonists. Hollingsworth LR, Veeraraghavan P, Paulo JA, Harper JW, Rauch I. bioRxiv [Preprint]. 2024 Apr 20:2024.04.19.590338. doi: 10.1101/2024.04.19.590338. PubMed | 
| C16ORF70/MYTHO promotes healthy aging in C.elegans and prevents cellular senescence in mammals. Franco-Romero A, Morbidoni V, Milan G, Sartori R, Wulff J, Romanello V, Armani A, Salviati L, Conte M, Salvioli S, Franceschi C, Buonomo V, Swoboda CO, Grumati P, Pannone L, Martinelli S, Jefferies HB, Dikic I, van der Laan J, Cabreiro F, Millay DP, Tooze SA, Trevisson E, Sandri M. J Clin Invest. 2024 Jun 13;134(15):e165814. doi: 10.1172/JCI165814. PubMed | 
| DMXL1 promotes recruitment of V1-ATPase to lysosomes upon TRPML1 activation. Lee C, Eldridge MJG, Gonzalez-Lozano MA, Bresnahan T, Niday Z, Del Camino D, Fu T, Paulo JA, Moran MM, Helaine S, Harper JW. Nat Struct Mol Biol. 2025 Oct;32(10):2060-2075. doi: 10.1038/s41594-025-01581-x. Epub 2025 Jun 17. PubMed | 
If you have published an article using this material, please email us at [email protected] to have your article added to this page.